Spotlight Innovation Forms Partnership with the University of Iowa Athletics

- September 27th, 2017

Spotlight Innovation announced that it has formed a corporate partnership with the University of Iowa Athletics that will provide ongoing radio and digital media visibility for the Venodol brand and for Venodol Roll-on.

Spotlight Innovation (OTCQB:STLT) announced that it has formed a corporate partnership with the University of Iowa Athletics that will provide ongoing radio and digital media visibility for the Venodol brand and for Venodol Roll-on.
As quoted in the press release:

Venodol Roll-on, a new chronic pain relief product from Spotlight Innovation subsidiary Caretta Therapeutics, is a non-opioid, non-addictive topical analgesic formulated to provide long-lasting relief from chronic pain associated with inflammation. The multi-year partnership was secured on behalf of the University of Iowa by Learfield’s Hawkeye Sports Properties, UI Athletics’ multimedia rightsholder.
The corporate partner relationship encompasses Hawkeye Football, Men’s Basketball and Wrestling during the respective athletic seasons, and focuses on network radio and social media visibility.

Click here to read the full press release.

Source: www.marketwired.com

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All

Leave a Reply